Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Agammaglobulinaemia tyrosine kinase

EU orphan designation number: EU/3/17/1951   
Active ingredient: Agammaglobulinaemia tyrosine kinase
Indication: Treatment of pemphigus
Sponsor: Clinical Network Services (NL) B.V.
De Cuserstraat 93, 1081 CN Amsterdam, Noord-Holland, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2017 Orphan designation EMA/OD/157/17 (2017)8783 of 12/12/2017
4/02/2019 Transfer of orphan designation EMA/OD/0000002857 (2019)817 of 30/01/2019